📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
7 articles scientifiques publiés — formation continue solide
Référence presse grand public
Cité 5 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
5
5 articles ont été cités au moins 5fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
2 209
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
39
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
4
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Hospimedia · 20/11/2024
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPYTI5dDU0SjFsMDRkbXRRekEwdU8xdHN0RXRTcV9uTmdaVkltQnBWaVdRQzJOa1h4UTNmUkw4SnhKZ0NEMHFjOTRjYWoxR0VQbElVeDRGcVVOVkNZX1M3REV5dnpYcE0yaVVsUHdQWWJmWEpyTF83Qy1PalhGT0o5ak1jdDFNbmpqOXZieUVwUDdIOEVJR2R1cmppeEZrLXhlRDZudGl5c1BmcmZlaXVkZ1dVYVRFdw?oc=
📰 lanouvellerepublique.fr · 09/06/2015
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxPbm00QzByOWotUm14NDZsR194cDFBeWhlT0FMTFRSS1o1S3hNcnZ4UGtrZlMxMVN1bTUtblhBdEI4NTc5VHhFTnZqRnVpOWNQTHVoZU5VNk52Wk5JREQzLUxjU0pOdURncURpcHR1MVJXa2dmc2oxTTQxNUxWV0IzWDNuTTctUXBpanRTcVpIQUQyWkRnQ1JlTGN3?oc=5" target="_blank">Le service médical
📰 Ouest-France · 21/11/2014
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOM0QtM2JrZVNYcnp0WDZURVFrUGIxcVlRbG9UTUFLQk82Z1J6OUFwVW83LVdEMWZqTEdlZWljTndTNHU3aGVZMkxhSUNRUnkzSTlaRTZLZGM0aVpwaDhRcHVRM3M1c1huZDN2eGhHb2dQQmcwQi0weFlma3hRaGkzMWszS0ZvVW1zclBOTTg5MVd2eTdnSUJNc21tbW5GaUFMYkl3?oc=5" target="_blank">Les lyc
📰 Ouest-France · 02/02/2026
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxOMF9xNlM1b0l5VjAzdjdqZ3JkbmFBTTM0NGhkSWF1dVBmZm9VMTRZOGRrZXN5RUZzVGFrUndPOWVlUzh0cGRZOFJRUm54bXdnWUs0UndfRmNiN3FOUG55d1RVVjlHNThlUG9NMVFiQmFFb3JUQk5oR2NXcFNZdEdLUk0zQ0dFMERmeEZ4dkg3RmZZWUtjMWE3TVNPcjN4VTVxbFBCczBTX3F0VnRJdDgtMDV2S19vWUJMSn
📰 RTBF · 14/10/2015
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxORmx6bnBPZVQwVldsaG54VUNKVnd0TWRmTGt0ejZfb1BMUHJuS1RNQnZiaVNNWnFmYU9EYVUxaTYxM3J0TVRvMHdELVVfVmVTc3I2bG43MnFmQnpwNl91RFh0d2diaDQwZndpSEdfRXJhSnQybzBOSDlMcUM5YURKXzhCUFpRSEFZSDB0bzdB?oc=5" target="_blank">Amay: la maison de repos "L'Estérel
Arthritis care & research · 2012
AbstractObjectiveDespite the importance of achieving tight control, many patients with rheumatoid arthritis (RA) are not effectively treated with disease‐modifying antirheumatic drugs. The objective of this study was to develop a decision support tool to inform RA patients with ongoing active disease about the risks and benefits related to biologic therapy.MethodsWe developed a balanced, web‐based, decision support tool. Options, values, and probabilistic information were described using theoretically supported formulations. We conducted a pre‐/posttest study to assess preliminary evidence of the tool's efficacy in improving knowledge related to biologics, clarity of values, willingness to take a biologic, and informed choice.ResultsWe interviewed 104 subjects (mean age 62 years, 84% women, 87% white, and median duration of RA 8 years). Knowledge (coded on a 0–20 scale) and willingness to take a biologic (coded on a 0–10 scale) significantly increased after viewing the tool (mean differences 2.3 and 1.4, respectively; P < 0.0001 for both). Perceived knowledge and values clarity (coded on 0–100 scales) also significantly improved (mean differences 20.4 and 20.8, respectively; P < 0.0001 for both). The proportion of subjects making an informed value‐concordant choice increased substantially from 35% to 64%.ConclusionA tool designed to effectively communicate the risks and benefits associated with biologic therapy increased knowledge, patient willingness to escalate care, and the likelihood of making an informed choice. The results of this study support the need for a clinical trial to examine the impact of the tool in clinical practice.
Journal of the American Geriatrics Society · 2017
In response to the epidemic of falls and serious falls‐related injuries in older persons, in 2014, the Patient Centered Outcomes Research Institute ( PCORI ) and the National Institute on Aging funded a pragmatic trial, Strategies to Reduce Injuries and Develop confidence in Elders ( STRIDE ) to compare the effects of a multifactorial intervention with those of an enhanced usual care intervention. The STRIDE multifactorial intervention consists of five major components that registered nurses deliver in the role of falls care managers, co‐managing fall risk in partnership with patients and their primary care providers ( PCP s). The components include a standardized assessment of eight modifiable risk factors (medications; postural hypotension; feet and footwear; vision; vitamin D; osteoporosis; home safety; strength, gait, and balance impairment) and the use of protocols and algorithms to generate recommended management of risk factors; explanation of assessment results to the patient (and caregiver when appropriate) using basic motivational interviewing techniques to elicit patient priorities, preferences, and readiness to participate in treatments; co‐creation of individualized falls care plans that patients’ PCP s review, modify, and approve; implementation of the falls care plan; and ongoing monitoring of response, regularly scheduled re‐assessments of fall risk, and revisions of the falls care plan. Custom‐designed falls care management software facilitates risk factor assessment, the identification of recommended interventions, clinic note generation, and longitudinal care management. The trial testing the effectiveness of the STRIDE intervention is in progress, with results expected in late 2019.
Arthritis care & research · 2015
ObjectiveTo examine the potential value of a theory‐based, interactive decision support tool in clinical practice for patients with rheumatoid arthritis who are candidates for biologic agents.MethodsWe conducted an 8‐week, 2‐arm, parallel, single‐blind pilot trial in which candidates for treatment escalation with a biologic agent were randomized to receive either a link to a web‐based tool or usual care. Outcomes included changes in objective knowledge, subjective knowledge, values clarification, and satisfaction with risk communication as well as the proportion of subjects defined as making an informed choice to escalate care at 2 weeks.ResultsA total of 125 subjects were randomized. Significant between‐group differences at 2 weeks favoring the intervention group were seen for changes in objective knowledge, subjective knowledge, and values clarification. No significant between‐group differences were found in subjects’ satisfaction with risk communication. Among those deciding to escalate care, a greater percentage met the criteria for an informed choice at 2 weeks in the intervention group compared to the control group (32% versus 13%; P = 0.02). Improvements in subjective knowledge and values clarification persisted at 8 weeks. There were no between‐group differences in objective knowledge at 8 weeks.ConclusionIn this study, use of a decision support tool at the time of decision‐making resulted in improved objective and subjective knowledge, as well as values clarity, compared to usual care. Not all improvements were sustained, emphasizing the need to offer educational support should additional escalation of care be required over the course of the illness.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Public understanding of science (Bristol, England) · 2024 · Journal Article
Mori M, Longépée E, Lefer-Sauvage G, Banos A, et al.
Somatosensory & motor research · 2020 · Journal Article
Viseux FJF, Martins DF, Villeneuve P, Charpentier P, et al.
Journal of the American Geriatrics Society · 2017 · Journal Article
Reuben DB, Gazarian P, Alexander N, Araujo K, et al.
Arthritis care & research · 2015 · Journal Article
Fraenkel L, Matzko CK, Webb DE, Oppermann B, et al.
Arthritis care & research · 2012 · Journal Article
Fraenkel L, Peters E, Charpentier P, Olsen B, et al.
Revue neurologique · 2004 · Case Reports
Simonin C, Devos D, de Seze J, Charpentier P, et al.
Dakar medical · 2006 · Case Reports
Thiam M, Fall MD, Calvet P, Fall PD, et al.